Recro Pharma: 3Q Earnings Snapshot

November 7, 2018

MALVERN, Pa. (AP) _ Recro Pharma Inc. (REPH) on Wednesday reported a loss of $13.3 million in its third quarter.

The Malvern, Pennsylvania-based company said it had a loss of 64 cents per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 67 cents per share.

The specialty pharmaceutical company posted revenue of $18.3 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $16.8 million.

Recro Pharma shares have decreased 25 percent since the beginning of the year. The stock has decreased 21 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on REPH at https://www.zacks.com/ap/REPH

Update hourly